摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-氨基-3-羟基-3-甲基丁酸 | 2280-28-6

中文名称
(R)-2-氨基-3-羟基-3-甲基丁酸
中文别名
(R,s)-2-氨基-3-羟基-3-甲基丁酸;3-甲基苏氨酸;2-氨基-3-羟基-3-甲基丁酸;(R,S)-2-氨基-3-羟基-3-甲基丁酸
英文名称
3-hydroxy-DL-valine
英文别名
3-Hydroxy-DL-valin;2-amino-3-hydroxy-3-methylbutyric acid;2-azaniumyl-3-hydroxy-3-methylbutanoate
(R)-2-氨基-3-羟基-3-甲基丁酸化学式
CAS
2280-28-6
化学式
C5H11NO3
mdl
——
分子量
133.147
InChiKey
LDRFQSZFVGJGGP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    200-202 °C
  • 沸点:
    245.66°C (rough estimate)
  • 密度:
    1.2510 (rough estimate)
  • 溶解度:
    PBS(pH 7.2):2 mg/ml

计算性质

  • 辛醇/水分配系数(LogP):
    -2.8
  • 重原子数:
    9
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    83.6
  • 氢给体数:
    3
  • 氢受体数:
    4

安全信息

  • 安全说明:
    S24/25
  • 海关编码:
    2922509090

SDS

SDS:4a560c21a2a43396a37a62a5f144d995
查看
Name: (R S)-2-Amino-3-hydroxy-3-methylbutanoic acid 99+% Material Safety Data Sheet
Synonym: 3-Hydroxyvaline
CAS: 2280-28-6
Section 1 - Chemical Product MSDS Name:(R S)-2-Amino-3-hydroxy-3-methylbutanoic acid 99+% Material Safety Data Sheet
Synonym:3-Hydroxyvaline

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
2280-28-6 (R,S)-2-Amino-3-hydroxy-3-methylbutano >99 unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
May cause respiratory tract irritation.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Use with adequate ventilation.
Avoid breathing dust.
Storage:
Store in a cool, dry place. Keep container closed when not in use.
Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 2280-28-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 200 - 202 deg C
Autoignition Temperature: Not available.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C5H11NO3
Molecular Weight: 133.15

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 2280-28-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(R,S)-2-Amino-3-hydroxy-3-methylbutanoic acid - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 2280-28-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 2280-28-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2280-28-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    β-羟基缬氨酸的合成、拆分和构型
    摘要:
    DL-β-羟基缬氨酸是由β,β-二甲基缩水甘油酸钠通过苯甲胺氨解,然后氢解合成的。N-苯甲酰基-DL-β-羟基缬氨酸通过使用 (-)-α-甲基苄胺进行拆分,得到 (-)-N-苯甲酰基-β-羟基缬氨酸。VI 的构型通过将其转化为 N-苯甲酰基-β-氯缬氨酸甲酯 (I) 和随后的 I 氢解得到 (-) 甲基 N-苯甲酰基缬氨酸 (II) 来确定。从II,水解后获得光学纯的D-(-)-缬氨酸。
    DOI:
    10.1246/bcsj.39.2287
  • 作为产物:
    参考文献:
    名称:
    A Novel Synthesis of β-Hydroxyvaline
    摘要:
    从乙基β,β-二甲基丙烯酸酯经过1,2-二(乙氧羰基)-3,3-二甲基环氧乙烷作为中间体合成β-羟基缬氨酸,展示了一种新的合成该氨基酸的方法。
    DOI:
    10.1139/v71-430
点击查看最新优质反应信息

文献信息

  • Synthesis of α-amino-β-hydroxy acids using -bis(trimethylsilyl)aminoketene bis(trimethylsilyl) acetal or its -methyl--trimethylsilyl analog
    作者:Torsten Hvidt、Olivier R. Martin、Walter A. Szarek
    DOI:10.1016/s0040-4039(00)83885-x
    日期:1986.1
    Condensation of the title compounds with aldehydes and ketones in the presence of trimethylsilyl triflate provided the corresponding α-amino-β-hydroxy acids in fair to good yields as a mixture of diastereomers.
    三氟甲磺酸三甲基甲硅烷基酯的存在下,标题化合物与醛和酮的缩合以非对映异构体混合物的形式以相当高的收率提供了相应的α-基-β-羟基酸。
  • Etude par la modélisation moléculaire de la régiosélectivité de l'Ouverture des acides glycidiques par les amines aliphatiques
    作者:F. Grosjean、M. Huché、M. Larchevêque、J.J. Legendre、Y. Petit
    DOI:10.1016/s0040-4020(01)85509-5
    日期:——
    A model for glycidic acids opening reaction by ammonia and amines has been suggested from semi-empiric orbital calculations. It provides a way for evaluating the different interactions between the incoming nucleophile and the oxirane substituents. Steric and coulombic interactions of the carboxylate in staggered conformation (cis substitution) has a major influence to rationalize experimental regioselectivity
    从半经验轨道计算中已经提出了由和胺引起的缩水甘油酸打开反应的模型。它提供了一种评估传入的亲核试剂与环氧乙烷取代基之间不同相互作用的方法。交错构象(顺式取代)中羧酸盐的立体和库仑相互作用对合理化实验区域选择性具有重大影响。
  • β-Lactam synthesis: Chemospecific sulfonation and cyclization of the β-hydroxyvaline nucleus
    作者:W.A Slusarchyk、T Dejneka、J Gougoutas、W.H Koster、D.R Kronenthal、M Malley、M.G Perri、F.L Routh、J.E Sundeen、E.R Weaver、R Zahler、J.D Godfrey、R.H Mueller、D.J Von Langen
    DOI:10.1016/s0040-4039(00)84643-2
    日期:1986.1
    intramolecular cyclization of “hydroxamate” using Mitsunobu conditions was inefficient for the formation and isolation of the C-4 dimethyl monobactam . However, chemospecific O-sulfonation of 1 and subsequent cyclization with base provides a useful method for β-lactam synthesis from a sterically hindered β-hydroxy amino acid. Competitive rearrangement of also occurs during cyclization providing isomeric
    使用Mitsunobu条件的“异羟酸酯”的分子内环化对于形成和分离C-4二甲基单bactam效率低下。然而,1的化学特异性O磺化以及随后的碱环化为从位阻β-羟基氨基酸合成β-内酰胺提供了一种有用的方法。在环化过程中也会发生竞争性重排,提供异构体β-内酰胺。
  • Zur Synthese von β-Oxy-valin. Vereinfachte Darstellung der α-Brom-β-methoxy-isovaleriansäure
    作者:K. Rüfenacht
    DOI:10.1002/hlca.19520350309
    日期:1952.5.2
    1. Zur Zinkbestimmung in Cadmium-Zink-Legierungen mit 0,05 bis 10% Zn wird eine funkenspektrographische Methode beschrieben mit Verwendung eines reinen Cadmiumstabes als Gegenelektrode.
    1.为了测定含量为0.05%到10%的中的,描述了一种使用纯棒作为对电极的火花光谱法。
  • Behrens et al., Journal of Biological Chemistry, 1948, vol. 175, p. 771,778
    作者:Behrens et al.
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸